 | • レポートコード：MRC2012B0190 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、慢性特発性便秘治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性特発性便秘治療薬の種類別市場規模（リナクロチド、ルビプロストン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Allergens、Sanofi、Glaxosmithkline、Eli Lilly、Roche Holding AG、Ferring International Center S.A、Merck、Bayer AG、Chugai Pharmaceutical、Bausch Health、Progenics Pharmaceuticals Inc、Synergy Pharmaceuticals、Daiichi Sankyo、Ironwood Pharmaceuticals Inc、Salix Pharmaceuticals Ltd、Theravance Biopharma Inc、Cosmo Pharmaceuticals SA、Sucampo Pharmaceuticals Inc、 ・地域別グローバル市場分析 2015年-2020年 ・慢性特発性便秘治療薬の北米市場（アメリカ、カナダ、メキシコ） ・慢性特発性便秘治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・慢性特発性便秘治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・慢性特発性便秘治療薬の南米市場（ブラジル、アルゼンチン） ・慢性特発性便秘治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リナクロチド、ルビプロストン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Chronic Idiopathic Constipation Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Chronic Idiopathic Constipation Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chronic Idiopathic Constipation Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chronic Idiopathic Constipation Drugs market has been segmented into:
Linaclotide
Lubiprostone
Other
By Application, Chronic Idiopathic Constipation Drugs has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Idiopathic Constipation Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Idiopathic Constipation Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Idiopathic Constipation Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Chronic Idiopathic Constipation Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Chronic Idiopathic Constipation Drugs Market Share Analysis
Chronic Idiopathic Constipation Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Idiopathic Constipation Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Idiopathic Constipation Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Chronic Idiopathic Constipation Drugs are:
Pfizer
Allergens
Sanofi
Glaxosmithkline
Eli Lilly
Roche Holding AG
Ferring International Center S.A
Merck
Bayer AG
Chugai Pharmaceutical
Bausch Health
Progenics Pharmaceuticals Inc
Synergy Pharmaceuticals
Daiichi Sankyo
Ironwood Pharmaceuticals Inc
Salix Pharmaceuticals Ltd
Theravance Biopharma Inc
Cosmo Pharmaceuticals SA
Sucampo Pharmaceuticals Inc
Table of Contents
1 Chronic Idiopathic Constipation Drugs Market Overview
1.1 Product Overview and Scope of Chronic Idiopathic Constipation Drugs
1.2 Classification of Chronic Idiopathic Constipation Drugs by Type
1.2.1 Global Chronic Idiopathic Constipation Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type in 2019
1.2.3 Linaclotide
1.2.4 Lubiprostone
1.2.5 Other
1.3 Global Chronic Idiopathic Constipation Drugs Market by Application
1.3.1 Overview: Global Chronic Idiopathic Constipation Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Chronic Idiopathic Constipation Drugs Market by Regions
1.4.1 Global Chronic Idiopathic Constipation Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chronic Idiopathic Constipation Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chronic Idiopathic Constipation Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chronic Idiopathic Constipation Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Idiopathic Constipation Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chronic Idiopathic Constipation Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Idiopathic Constipation Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Allergens
2.2.1 Allergens Details
2.2.2 Allergens Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Allergens SWOT Analysis
2.2.4 Allergens Product and Services
2.2.5 Allergens Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Glaxosmithkline
2.4.1 Glaxosmithkline Details
2.4.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Glaxosmithkline SWOT Analysis
2.4.4 Glaxosmithkline Product and Services
2.4.5 Glaxosmithkline Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche Holding AG
2.6.1 Roche Holding AG Details
2.6.2 Roche Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche Holding AG SWOT Analysis
2.6.4 Roche Holding AG Product and Services
2.6.5 Roche Holding AG Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ferring International Center S.A
2.7.1 Ferring International Center S.A Details
2.7.2 Ferring International Center S.A Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ferring International Center S.A SWOT Analysis
2.7.4 Ferring International Center S.A Product and Services
2.7.5 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer AG
2.9.1 Bayer AG Details
2.9.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer AG SWOT Analysis
2.9.4 Bayer AG Product and Services
2.9.5 Bayer AG Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Chugai Pharmaceutical
2.10.1 Chugai Pharmaceutical Details
2.10.2 Chugai Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Chugai Pharmaceutical SWOT Analysis
2.10.4 Chugai Pharmaceutical Product and Services
2.10.5 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bausch Health
2.11.1 Bausch Health Details
2.11.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bausch Health SWOT Analysis
2.11.4 Bausch Health Product and Services
2.11.5 Bausch Health Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Progenics Pharmaceuticals Inc
2.12.1 Progenics Pharmaceuticals Inc Details
2.12.2 Progenics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Progenics Pharmaceuticals Inc SWOT Analysis
2.12.4 Progenics Pharmaceuticals Inc Product and Services
2.12.5 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Synergy Pharmaceuticals
2.13.1 Synergy Pharmaceuticals Details
2.13.2 Synergy Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Synergy Pharmaceuticals SWOT Analysis
2.13.4 Synergy Pharmaceuticals Product and Services
2.13.5 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Daiichi Sankyo
2.14.1 Daiichi Sankyo Details
2.14.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Daiichi Sankyo SWOT Analysis
2.14.4 Daiichi Sankyo Product and Services
2.14.5 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ironwood Pharmaceuticals Inc
2.15.1 Ironwood Pharmaceuticals Inc Details
2.15.2 Ironwood Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Ironwood Pharmaceuticals Inc SWOT Analysis
2.15.4 Ironwood Pharmaceuticals Inc Product and Services
2.15.5 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.16 Salix Pharmaceuticals Ltd
2.16.1 Salix Pharmaceuticals Ltd Details
2.16.2 Salix Pharmaceuticals Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Salix Pharmaceuticals Ltd SWOT Analysis
2.16.4 Salix Pharmaceuticals Ltd Product and Services
2.16.5 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.17 Theravance Biopharma Inc
2.17.1 Theravance Biopharma Inc Details
2.17.2 Theravance Biopharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Theravance Biopharma Inc SWOT Analysis
2.17.4 Theravance Biopharma Inc Product and Services
2.17.5 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.18 Cosmo Pharmaceuticals SA
2.18.1 Cosmo Pharmaceuticals SA Details
2.18.2 Cosmo Pharmaceuticals SA Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Cosmo Pharmaceuticals SA SWOT Analysis
2.18.4 Cosmo Pharmaceuticals SA Product and Services
2.18.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sucampo Pharmaceuticals Inc
2.19.1 Sucampo Pharmaceuticals Inc Details
2.19.2 Sucampo Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sucampo Pharmaceuticals Inc SWOT Analysis
2.19.4 Sucampo Pharmaceuticals Inc Product and Services
2.19.5 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chronic Idiopathic Constipation Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Idiopathic Constipation Drugs Players Market Share
3.2.2 Top 10 Chronic Idiopathic Constipation Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chronic Idiopathic Constipation Drugs Revenue and Market Share by Regions
4.2 North America Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
5 North America Chronic Idiopathic Constipation Drugs Revenue by Countries
5.1 North America Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
5.2 USA Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
6 Europe Chronic Idiopathic Constipation Drugs Revenue by Countries
6.1 Europe Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
6.2 Germany Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
6.4 France Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue by Countries
7.1 Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
7.2 China Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
7.5 India Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
8 South America Chronic Idiopathic Constipation Drugs Revenue by Countries
8.1 South America Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
8.2 Brazil Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chronic Idiopathic Constipation Drugs by Countries
9.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chronic Idiopathic Constipation Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Chronic Idiopathic Constipation Drugs Market Forecast by Type (2019-2024)
10.3 Linaclotide Revenue Growth Rate (2015-2025)
10.4 Lubiprostone Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Chronic Idiopathic Constipation Drugs Market Segment by Application
11.1 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2015-2020)
11.2 Chronic Idiopathic Constipation Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Chronic Idiopathic Constipation Drugs Market Size Forecast (2021-2025)
12.1 Global Chronic Idiopathic Constipation Drugs Market Size Forecast (2021-2025)
12.2 Global Chronic Idiopathic Constipation Drugs Market Forecast by Regions (2021-2025)
12.3 North America Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
12.6 South America Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Chronic Idiopathic Constipation Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Idiopathic Constipation Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Idiopathic Constipation Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chronic Idiopathic Constipation Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Chronic Idiopathic Constipation Drugs Major Business
Table 7. Pfizer Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Chronic Idiopathic Constipation Drugs Product and Solutions
Table 10. Pfizer Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Allergens Corporate Information, Location and Competitors
Table 12. Allergens Chronic Idiopathic Constipation Drugs Major Business
Table 13. Allergens Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Allergens SWOT Analysis
Table 15. Allergens Chronic Idiopathic Constipation Drugs Product and Solutions
Table 16. Allergens Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Chronic Idiopathic Constipation Drugs Major Business
Table 19. Sanofi Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Chronic Idiopathic Constipation Drugs Product and Solutions
Table 22. Sanofi Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Glaxosmithkline Corporate Information, Location and Competitors
Table 24. Glaxosmithkline Chronic Idiopathic Constipation Drugs Major Business
Table 25. Glaxosmithkline Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Glaxosmithkline SWOT Analysis
Table 27. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product and Solutions
Table 28. Glaxosmithkline Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly Chronic Idiopathic Constipation Drugs Major Business
Table 31. Eli Lilly Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly Chronic Idiopathic Constipation Drugs Product and Solutions
Table 34. Eli Lilly Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Holding AG Corporate Information, Location and Competitors
Table 36. Roche Holding AG Chronic Idiopathic Constipation Drugs Major Business
Table 37. Roche Holding AG Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Roche Holding AG SWOT Analysis
Table 39. Roche Holding AG Chronic Idiopathic Constipation Drugs Product and Solutions
Table 40. Roche Holding AG Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ferring International Center S.A Corporate Information, Location and Competitors
Table 42. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Major Business
Table 43. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Ferring International Center S.A SWOT Analysis
Table 45. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product and Solutions
Table 46. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck Chronic Idiopathic Constipation Drugs Major Business
Table 49. Merck Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck Chronic Idiopathic Constipation Drugs Product and Solutions
Table 52. Merck Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bayer AG Corporate Information, Location and Competitors
Table 54. Bayer AG Chronic Idiopathic Constipation Drugs Major Business
Table 55. Bayer AG Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Bayer AG SWOT Analysis
Table 57. Bayer AG Chronic Idiopathic Constipation Drugs Product and Solutions
Table 58. Bayer AG Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Chugai Pharmaceutical Corporate Information, Location and Competitors
Table 60. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Major Business
Table 61. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Chugai Pharmaceutical SWOT Analysis
Table 63. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product and Solutions
Table 64. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bausch Health Corporate Information, Location and Competitors
Table 66. Bausch Health Chronic Idiopathic Constipation Drugs Major Business
Table 67. Bausch Health Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Bausch Health SWOT Analysis
Table 69. Bausch Health Chronic Idiopathic Constipation Drugs Product and Solutions
Table 70. Bausch Health Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Progenics Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 72. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Business
Table 73. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 74. Progenics Pharmaceuticals Inc SWOT Analysis
Table 75. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Solutions
Table 76. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Synergy Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Major Business
Table 79. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 80. Synergy Pharmaceuticals SWOT Analysis
Table 81. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product and Solutions
Table 82. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Daiichi Sankyo Corporate Information, Location and Competitors
Table 84. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Major Business
Table 85. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 86. Daiichi Sankyo SWOT Analysis
Table 87. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product and Solutions
Table 88. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Ironwood Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 90. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Business
Table 91. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 92. Ironwood Pharmaceuticals Inc SWOT Analysis
Table 93. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Solutions
Table 94. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Salix Pharmaceuticals Ltd Corporate Information, Location and Competitors
Table 96. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Major Business
Table 97. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 98. Salix Pharmaceuticals Ltd SWOT Analysis
Table 99. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product and Solutions
Table 100. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Theravance Biopharma Inc Corporate Information, Location and Competitors
Table 102. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Major Business
Table 103. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 104. Theravance Biopharma Inc SWOT Analysis
Table 105. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product and Solutions
Table 106. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Type and Application
Table 108. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Major Business
Table 109. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 110. Cosmo Pharmaceuticals SA SWOT Analysis
Table 111. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product and Solutions
Table 112. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Sucampo Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 114. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Business
Table 115. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Total Revenue (USD Million) (2017-2018)
Table 116. Sucampo Pharmaceuticals Inc SWOT Analysis
Table 117. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product and Solutions
Table 118. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Players (2015-2020)
Table 120. Global Chronic Idiopathic Constipation Drugs Revenue Share by Players (2015-2020)
Table 121. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Regions (2015-2020)
Table 123. North America Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
Table 124. North America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 125. Europe Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Chronic Idiopathic Constipation Drugs Revenue by Countries (2015-2020)
Table 128. South America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Table 131. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) by Type (2015-2020)
Table 132. Global Chronic Idiopathic Constipation Drugs Revenue Share by Type (2015-2020)
Table 133. Global Chronic Idiopathic Constipation Drugs Revenue Forecast by Type (2021-2025)
Table 134. Global Chronic Idiopathic Constipation Drugs Revenue by Application (2015-2020)
Table 135. Global Chronic Idiopathic Constipation Drugs Revenue Share by Application (2015-2020)
Table 136. Global Chronic Idiopathic Constipation Drugs Revenue Forecast by Application (2021-2025)
Table 137. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chronic Idiopathic Constipation Drugs Picture
Figure 2. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type in 2019
Figure 3. Linaclotide Picture
Figure 4. Lubiprostone Picture
Figure 5. Other Picture
Figure 6. Chronic Idiopathic Constipation Drugs Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Chronic Idiopathic Constipation Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Chronic Idiopathic Constipation Drugs Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Chronic Idiopathic Constipation Drugs Revenue Market Share in 2019
Figure 19. Global Top 10 Players Chronic Idiopathic Constipation Drugs Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Regions (2015-2020)
Figure 23. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Regions in 2018
Figure 24. North America Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Europe Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 27. South America Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 29. North America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Figure 30. North America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries in 2019
Figure 31. USA Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Canada Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Europe Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries in 2019
Figure 36. Germany Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 37. UK Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 38. France Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Russia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Italy Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries in 2019
Figure 43. China Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Japan Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Korea Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 46. India Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 48. South America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. South America Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries in 2019
Figure 50. Brazil Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 55. UAE Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Global Chronic Idiopathic Constipation Drugs Revenue Share by Type (2015-2020)
Figure 59. Global Chronic Idiopathic Constipation Drugs Revenue Share by Type in 2019
Figure 60. Global Chronic Idiopathic Constipation Drugs Market Share Forecast by Type (2021-2025)
Figure 61. Global Linaclotide Revenue Growth Rate (2015-2020)
Figure 62. Global Lubiprostone Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Chronic Idiopathic Constipation Drugs Revenue Share by Application (2015-2020)
Figure 65. Global Chronic Idiopathic Constipation Drugs Revenue Share by Application in 2019
Figure 66. Global Chronic Idiopathic Constipation Drugs Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Chronic Idiopathic Constipation Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Chronic Idiopathic Constipation Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
Figure 74. Europe Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
Figure 76. South America Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Chronic Idiopathic Constipation Drugs Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
慢性特発性便秘（CIC）治療薬の世界市場（～2026年） Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of diffi…- 慢性特発性骨髄線維症の世界市場（～2026年） Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…
- 便秘の世界市場（～2026年） Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing …
- オピオイド誘発性便秘（OIC）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioid Induced Constipation (OIC) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Opioi…
- 便秘治療の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Constipation Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 7296.1 million by 2025, from USD 6311.7 million in 2019. The Constipation …